Showing results (351-360 of 368) with videos related to
Sort By:
Pageof 37
Radiation Oncology (London, England)|February 8, 2023
Brain metastases in Japanese NSCLC patients: prognostic assessment and the use of osimertinib and immune checkpoint inhibitors-retrospective studyHajime Higaki, Kentaro Nishioka, Manami Otsuka, et al.Physics and Imaging in Radiation Oncology|January 16, 2025
Normal tissue complication probability model for severe radiation-induced lymphopenia in patients with pancreatic cancer treated with concurrent chemoradiotherapyFuki Koizumi, Norio Katoh, Takahiro Kanehira, et al.Annals of Surgery|July 30, 2024
Artificial Intelligence to Predict the Risk of Lymph Node Metastasis in T2 Colorectal CancerKatsuro Ichimasa, Caterina Foppa, Shin-Ei Kudo, et al.World Journal of Clinical Cases|December 14, 2021
Clinicopathological features of small T1 colorectal cancersYuki Takashina, Shin-Ei Kudo, Katsuro Ichimasa, et al.Scientific Reports|December 1, 2021
First-line osimertinib in elderly patients with epidermal growth factor receptor-mutated advanced non-small cell lung cancer: a retrospective multicenter study (HOT2002)Gaku Yamamoto, Hajime Asahina, Osamu Honjo, et al.DEN Open|December 2, 2024
Lymph node metastasis risk factors in T2 colorectal cancerYuriko Morita, Shin-Ei Kudo, Yuki Takashina, et al.Iscience|June 10, 2025
Porphyran from discolored nori prevents metabolic syndrome through microbiota-bile acid-ceramide pathwayYoko Yokoyama, Yoko Takashina, Jean-David Morel, et al.Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society|November 24, 2021
Beyond complete endoscopic healing: Goblet appearance using an endocytoscope to predict future sustained clinical remission in ulcerative colitisKazumi Takishima, Yasuharu Maeda, Noriyuki Ogata, et al.Respiratory Investigation|March 19, 2025
Prognostic impact of oligometastasis in older patients with extensive-stage small cell lung cancerDaisuke Morinaga, Kana Hashimoto, Hajime Asahina, et al.JTO Clinical and Research Reports|October 15, 2024
Synchronous Oligometastasis and Oligoprogression as a Prognostic Marker in Patients With Extensive-Stage SCLC Treated With a Combination of Immune-Checkpoint Inhibitor and Chemotherapy (HOT2301)Kana Hashimoto, Daisuke Morinaga, Hajime Asahina, et al.Pageof 37